Zobrazeno 1 - 10
of 51
pro vyhledávání: '"F, Sorbette"'
Publikováno v:
The Journal of rheumatology. 20(8)
Publikováno v:
Therapie. 48(2)
The eighties were characterized by the introduction of angiotensin converting enzyme inhibitors (ACEI) and calcium channel blockers (CCB) in the treatment of arterial hypertension. The present study investigates the side effects of antihypertensive d
Publikováno v:
Therapie. 48(2)
Autor:
F, Sorbette, I, Simon, J, Bonneterre, M, Clavel, M, David, M, Degardin, J P, Labat, I, Pinot, A, Thyss, J, Vignoud
Publikováno v:
Therapie. 47(5)
In a prospective, multicenter study, we evaluated the incidence of adverse cardiac effects in 1097 patients receiving 5-FU as a short i.v. perfusion or as a continuous perfusion over 3 to 5 days. There were 29 cardiac events (incidence 1.6%; 4.5% in
Publikováno v:
Therapie. 47(5)
Autor:
S, Gimenez, H, Bagheri, B, Marchou, P, Massip, J, Lafont, F, Sorbette, M, Armengaud, J L, Montastruc
Publikováno v:
Therapie. 45(5)
A therapeutic committee was established in Toulouse Regional University Hospital in order to prescribe zidovudine in patients suffering from AIDS. Using an informatic card, the side effects were evaluated in the 125 patients treated by Zidovudine sin
Publikováno v:
Bulletin du cancer. 77(5)
5-Fluorouracil (5FU) cardiotoxicity is thought to be an infrequent toxic effect, usually related to coronary vasospasm. Among 198 patients (pts) receiving 5FU as a continuous infusion (CI) over 96 or 120 h, at a daily dose of 1,000 mg/m2, 13 new case
Publikováno v:
La Revue de medecine interne. 8(2)
An intensive survey of pharmacovigilance was carried out in a medical admission department over a 4-month period. Out of 2,017 admissions to hospital, 23 (1,1 p. 100) were motivated by adverse reactions to drugs. Questioning brought out allergy and m
Publikováno v:
Therapie. 44(5)
Publikováno v:
Therapie. 38(3)